Reporting person on SEC Form 4

Brian Mueller

Brian Mueller is EVP, Chief Financial Officer at BioMarin Pharmaceutical. OQRO lists 7 transactions filed with the SEC under this name, the latest on Mar 19, 2026, each linked to the official Form 4.

EVP, Chief Financial Officer

Disclosures on record

7

Companies involved

1

Disclosure history

BioMarin PharmaceuticalBMRN
7 disclosures · Feb 2026 – Mar 2026
- Mar 17, 20262,117disclosed Mar 19
  Details Official record
- Mar 16, 202619Kdisclosed Mar 18
  Details Official record

Mar 16, 202645Kdisclosed Mar 18

Details Official record

Mar 13, 20269,945disclosed Mar 18

Details Official record

Feb 25, 20266,683disclosed Feb 27

Details Official record

Feb 25, 20267,230disclosed Feb 27

Details Official record

Feb 25, 20262,569disclosed Feb 27

Details Official record

All activity in BioMarin Pharmaceutical